199 related articles for article (PubMed ID: 12689746)
21. Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients.
Aravagiri M; Marder SR
J Pharm Biomed Anal; 2001 Sep; 26(2):301-11. PubMed ID: 11470207
[TBL] [Abstract][Full Text] [Related]
22. Distribution of clozapine and desmethylclozapine between blood and brain in rats.
Weigmann H; Härtter S; Fischer V; Dahmen N; Hiemke C
Eur Neuropsychopharmacol; 1999 Mar; 9(3):253-6. PubMed ID: 10208296
[TBL] [Abstract][Full Text] [Related]
23. Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia.
Ismail Z; Wessels AM; Uchida H; Ng W; Mamo DC; Rajji TK; Pollock BG; Mulsant BH; Bies RR
Am J Geriatr Psychiatry; 2012 Jan; 20(1):53-60. PubMed ID: 21422906
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic drug monitoring of clozapine and norclozapine in human serum using ultra-performance liquid chromatography- tandem mass spectrometry.
Ming DS; Heathcote J
J Anal Toxicol; 2009 May; 33(4):198-203. PubMed ID: 19470221
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the effects of clozapine and its metabolite norclozapine on metabolic dysregulation in rodent models.
Yuen JWY; Wu C; Wang CK; Kim DD; Procyshyn RM; Honer WG; Barr AM
Neuropharmacology; 2020 Sep; 175():107717. PubMed ID: 31348941
[TBL] [Abstract][Full Text] [Related]
26. Monitoring of clozapine and norclozapine plasma concentration-time curves in acute overdose.
Renwick AC; Renwick AG; Flanagan RJ; Ferner RE
J Toxicol Clin Toxicol; 2000; 38(3):325-8. PubMed ID: 10866334
[TBL] [Abstract][Full Text] [Related]
27. Clozapine--a dangerous drug in a clozapine-naïve subject.
Stanworth D; Hunt NC; Flanagan RJ
Forensic Sci Int; 2012 Jan; 214(1-3):e23-5. PubMed ID: 21831547
[TBL] [Abstract][Full Text] [Related]
28. Retrospective evaluation of therapeutic drug monitoring of clozapine and norclozapine in Belgium using a multidrug UHPLC-MS/MS method.
Patteet L; Maudens KE; Vermeulen Z; Dockx G; De Doncker M; Morrens M; Sabbe B; Neels H
Clin Biochem; 2014 Dec; 47(18):336-9. PubMed ID: 25289972
[TBL] [Abstract][Full Text] [Related]
29. Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia.
Guitton C; Kinowski JM; Abbar M; Chabrand P; Bressolle F
J Clin Pharmacol; 1999 Jul; 39(7):721-8. PubMed ID: 10392327
[TBL] [Abstract][Full Text] [Related]
30. Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics.
Li CH; Stratford RE; Velez de Mendizabal N; Cremers TI; Pollock BG; Mulsant BH; Remington G; Bies RR
J Transl Med; 2014 Aug; 12():203. PubMed ID: 25142323
[TBL] [Abstract][Full Text] [Related]
31. Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables.
Palego L; Biondi L; Giannaccini G; Sarno N; Elmi S; Ciapparelli A; Cassano GB; Lucacchini A; Martini C; Dell'Osso L
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):473-80. PubMed ID: 11999897
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal hypomotility: an under-recognised life-threatening adverse effect of clozapine.
Flanagan RJ; Ball RY
Forensic Sci Int; 2011 Mar; 206(1-3):e31-6. PubMed ID: 20719440
[TBL] [Abstract][Full Text] [Related]
33. Sensitive quantification of clozapine and its main metabolites norclozapine and clozapine-N-oxide in serum and urine using LC-MS/MS after simple liquid-liquid extraction work-up.
Wohlfarth A; Toepfner N; Hermanns-Clausen M; Auwärter V
Anal Bioanal Chem; 2011 May; 400(3):737-46. PubMed ID: 21394453
[TBL] [Abstract][Full Text] [Related]
34. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders.
Facciolà G; Avenoso A; Scordo MG; Madia AG; Ventimiglia A; Perucca E; Spina E
Ther Drug Monit; 1999 Jun; 21(3):341-5. PubMed ID: 10365650
[TBL] [Abstract][Full Text] [Related]
35. Clozapine: Dose, Sex, Ethnicity, Smoking Habit, Age, Body Weight, and Plasma Clozapine and N -Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice.
Flanagan RJ; Hunter S; Obee SJ; Reeves S
J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):131-138. PubMed ID: 36735578
[TBL] [Abstract][Full Text] [Related]
36. Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies.
Ruan CJ; Olmos I; Ricciardi C; Schoretsanitis G; Vincent PD; Anıl Yağcıoğlu AE; Eap CB; Baptista T; Clark SR; Fernandez-Egea E; Kim SH; Lane HY; Leung J; Maroñas Amigo O; Motuca M; Every-Palmer S; Procyshyn RM; Rohde C; Suhas S; Schulte PFJ; Spina E; Takeuchi H; Verdoux H; Correll CU; Molden E; De Las Cuevas C; de Leon J
Schizophr Res; 2024 Jun; 268():293-301. PubMed ID: 37487869
[TBL] [Abstract][Full Text] [Related]
37. Making sense of norclozapine levels: 3 clinical axioms.
Meyer JM
Schizophr Res; 2024 Jun; 268():289-292. PubMed ID: 37945386
[TBL] [Abstract][Full Text] [Related]
38. Determination of clozapine and its metabolite, norclozapine in various biological matrices using high-performance liquid chromatography.
Rosland M; Szeto P; Procyshyn R; Barr AM; Wasan KM
Drug Dev Ind Pharm; 2007 Oct; 33(10):1158-66. PubMed ID: 17963117
[TBL] [Abstract][Full Text] [Related]
39. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.
Consoli G; Lastella M; Ciapparelli A; Catena Dell'Osso M; Ciofi L; Guidotti E; Danesi R; Dell'Osso L; Del Tacca M; Di Paolo A
Pharmacogenomics; 2009 Aug; 10(8):1267-76. PubMed ID: 19663671
[TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.
Li LJ; Shang DW; Li WB; Guo W; Wang XP; Ren YP; Li AN; Fu PX; Ji SM; Lu W; Wang CY
Acta Pharmacol Sin; 2012 Nov; 33(11):1409-16. PubMed ID: 22820910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
